Showing results (261-270 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 14, 2018
Defining control of HIV epidemicsAlison P Galvani, Abhishek Pandey, Meagan C Fitzpatrick, et al.
The Lancet. HIV|October 12, 2018
Biometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerationsMatthew M Kavanagh, Stefan D Baral, Maureen Milanga, et al.
The Lancet. HIV|October 13, 2018
Evaluation of the HIV Infant Tracking System (HITSystem) to optimise quality and efficiency of early infant diagnosis: a cluster-randomised trial in KenyaSarah Finocchario-Kessler, Brad Gautney, AnLin Cheng, et al.
The Lancet. HIV|May 16, 2022
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck UkraineMarta Vasylyev, Agata Skrzat-Klapaczyńska, Jose I Bernardino, et al.
The Lancet. HIV|June 21, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trialJohn Frater, Katie J Ewer, Ane Ogbe, et al.
The Lancet. HIV|May 13, 2022
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, et al.
The Lancet. HIV|January 21, 2018
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trialJean-Michel Molina, Birgit Grund, Fred Gordin, et al.
The Lancet. HIV|December 12, 2018
Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical studyHelena Rabie, Paolo Denti, Janice Lee, et al.
The Lancet. HIV|June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort studyAdam Trickey, Lei Zhang, M John Gill, et al.
The Lancet. HIV|June 10, 2022
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lauren Greenberg, Jose M Miró, et al.
Pageof 79